4-hydroxybenzaldehyde has been researched along with Parkinson Disease in 2 studies
Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Kwon, J | 1 |
Hiep, NT | 1 |
Kim, DW | 1 |
Hong, S | 1 |
Guo, Y | 1 |
Hwang, BY | 1 |
Lee, HJ | 1 |
Mar, W | 1 |
Lee, D | 1 |
El-Sayed, HM | 1 |
El-Abassy, OM | 1 |
Abdellatef, HE | 1 |
Hendawy, HAM | 1 |
Ibrahim, H | 1 |
2 other studies available for 4-hydroxybenzaldehyde and Parkinson Disease
Article | Year |
---|---|
Chemical Constituents Isolated from the Root Bark of Cudrania tricuspidata and Their Potential Neuroprotective Effects.
Topics: Animals; Cell Death; Disease Models, Animal; Glucose; Ischemia; Moraceae; Neuroprotective Agents; Nu | 2016 |
Green Spectrophotometric Platforms for Resolving Overlapped Spectral Signals of Recently Approved Antiparkinsonian Drug (Safinamide) in the Presence of Its Synthetic Precursor (4-Hydroxybenzaldehyde): Applying Ecological Appraisal and Comparative Statisti
Topics: Alanine; Antiparkinson Agents; Benzylamines; Humans; Parkinson Disease | 2022 |